Trends in psychiatric disorders prevalence and prescription patterns of children in Alberta, Canada

Leung, Brenda; Kellett, Peter; Youngson, Erik; Hathaway, Josh; Santana, Maria Lydia Aroz D'Almeida

doi:10.1007/s00127-019-01714-w

Cited by 9 publications

(29 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Further, in the cohort by Engelmann et al, under a third of patients diagnosed with a psychiatric disorder had previously been in contact with a psychiatrist 30 . In register‐based studies on pIBD, the pooled prevalence rates of anxiety (6%) and depressive disorders (4%) is slightly higher than the 3%–5% and 2%–4% reported by two population‐based register studies from Sweden and Canada, including paediatric background populations 38,39 . Butwicka et al was the only included population‐based study and their reported prevalence rates of anxiety disorders (10%) and mood disorders (7%) was higher than in their background population of matched peers, where 6% and 4% were diagnosed with anxiety and mood disorders, respectively.…”

Section: Discussionmentioning

confidence: 91%

Psychiatric comorbidity in childhood onset immune‐mediated diseases—A systematic review and meta‐analysis

et al. 2022

View full text Add to dashboard Cite

Aim To estimate psychiatric comorbidity in childhood onset immune‐mediated inflammatory diseases (IMID). Methods The PRISMA guidelines were followed, and the protocol was registered at Prospero (ID: CRD42021233890). Literature was searched in PubMed, PsycINFO and Embase. Original papers on prevalence rates of diagnosed psychiatric disorders and/or suicide in paediatric onset inflammatory bowel disease (pIBD), rheumatic diseases (RD) and autoimmune liver diseases were selected. Pooled prevalence rates of psychiatric disorders (grouped according to ICD‐10 criteria) within the various IMID were calculated using random‐effects meta‐analysis. Risk of bias was evaluated by the Newcastle‐Ottawa scale. Results Twenty‐three studies were included; 13 describing psychiatric disorders in pIBD and 10 in RD. Anxiety and mood disorders were mostly investigated with pooled prevalence rates in pIBD of 6% (95% confidence interval (CI): 4%–9%) and 4% (95%CI: 2%–8%), respectively, in register‐based studies, and 33% (95%CI: 25%–41%) and 18% (95%CI: 12%–26%), respectively, in studies using psychiatric assessment. In RD, rates were 13% (95%CI: 12%–15%) for anxiety disorders and 20% (95%CI: 15%–26%) for mood disorders based on psychiatric assessment. Conclusion Anxiety and depression are commonly reported in childhood onset IMID. Physicians should be attentive to mental health problems in these patients as they seem overlooked.

show abstract

Section: Discussionmentioning

confidence: 91%

Psychiatric comorbidity in childhood onset immune‐mediated diseases—A systematic review and meta‐analysis

et al. 2022

View full text Add to dashboard Cite

show abstract

“…The range for data collection was similar for papers that focused on ADHD prevalence in children and/or adolescents (1999–2015/6) [ 11 , 15 , 17 , 18 , 20 ] and those that examined prevalence in adults (1999–2018) [ 13 , 14 , 15 , 16 , 19 ]. With regard to data collection methods used to derive estimates, some papers used primary care EMR data [ 12 ] and health administrative databases [ 15 , 16 , 17 , 18 , 20 ], whereas others used national/provincial surveys [ 11 , 13 , 14 , 19 ]. When papers included multiple prevalence or incidence estimates, the most recent estimate was used for this review [ 11 , 12 , 15 , 16 , 17 , 20 ].…”

Section: Resultsmentioning

confidence: 98%

“…A total of ten papers are included in the review [ 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 ], all of which were published from 2012 to 2022 (see Table 1 ). Ten papers included prevalence estimates of ADHD in Canada [ 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 ]. Out of these papers, one also examined the incidence of ADHD in Canada [ 15 ].…”

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

“…This group of studies based estimates on data collected from 1999 [ 11 , 20 ] to 2015/6 [ 12 , 17 , 20 ]. The range for data collection was similar for papers that focused on ADHD prevalence in children and/or adolescents (1999–2015/6) [ 11 , 15 , 17 , 18 , 20 ] and those that examined prevalence in adults (1999–2018) [ 13 , 14 , 15 , 16 , 19 ]. With regard to data collection methods used to derive estimates, some papers used primary care EMR data [ 12 ] and health administrative databases [ 15 , 16 , 17 , 18 , 20 ], whereas others used national/provincial surveys [ 11 , 13 , 14 , 19 ].…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

A Review of Canadian Diagnosed ADHD Prevalence and Incidence Estimates Published in the Past Decade

Espinet¹,

Graziosi

Toplak

et al. 2022

Brain Sciences

View full text Add to dashboard Cite

(1) Background: ADHD is recognized as one of the most common neurodevelopmental disorders. The worldwide prevalence of ADHD is estimated at 5.3%; however, estimates vary as a function of a number of factors, including diagnostic methods, age, sex and geographical location. A review of studies is needed to clarify the epidemiology of ADHD in Canada. (2) Methods: A search strategy was created in PubMed and adapted for MEDLINE and PsycINFO. Papers were included if they examined diagnosed ADHD prevalence and/or incidence rates in any region of Canada, age group and gender. A snowball technique was used to identify additional papers from reference lists, and experts in the field were consulted. (3) Results: Ten papers included in this review reported on prevalence, and one reported on incidence. One study provided an overall prevalence estimate across provinces for adults of 2.9%, and one study provided an overall estimate across five provinces for children and youth of 8.6%. Across age groups (1 to 24 years), incidence estimates ranged from 0.4% to 1.2%, depending on province. Estimates varied by age, gender, province, region and time. (4) Conclusions: The overall Canadian ADHD prevalence estimate is similar to worldwide estimates for adults. Most studies reported on prevalence rather than incidence. Differences in estimates across provinces may reflect the varying number of practitioners available to diagnose and prescribe medication for ADHD across provinces. To achieve a more comprehensive understanding of the epidemiology of ADHD in Canada, a study is needed that includes all provinces and territories, and that considers estimates in relation to age, gender, ethnicity, geographical region, socioeconomic status and access to mental healthcare coverage. Incidence rates need further examination to be determined.

show abstract

Pharmacotherapy for Preschool Children with Attention Deficit Hyperactivity Disorder (ADHD): Current Status and Future Directions

et al. 2021

View full text Add to dashboard Cite

Trends in psychiatric disorders prevalence and prescription patterns of children in Alberta, Canada

Cited by 9 publications

References 23 publications

Psychiatric comorbidity in childhood onset immune‐mediated diseases—A systematic review and meta‐analysis

Psychiatric comorbidity in childhood onset immune‐mediated diseases—A systematic review and meta‐analysis

A Review of Canadian Diagnosed ADHD Prevalence and Incidence Estimates Published in the Past Decade

Pharmacotherapy for Preschool Children with Attention Deficit Hyperactivity Disorder (ADHD): Current Status and Future Directions

Contact Info

Product

Resources

About